Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Atrium Therapeutics, Inc.NASDAQ: RNA

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income of -$16.63M in Q1 FY2026

Q1 FY2026 net income was -$16.63M.

Context

  • Net income amounted to 265.9% of revenue in FY2025.

What to watch

Whether net income reaches the consensus estimate from 3 analysts of -$56.38M (+13.9%) for the fiscal year ending Dec 2026.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$16.63M-42.9% QoQ
Last fiscal yearDec 2025
-$49.5M— YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year—+13.9%—
3-year CAGR—+24.3%—
5-year CAGR+8.5%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(49.5M) USD
Year-over-year change
—
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Net Income figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.